QBJ
- Product code
- QBJ
- Device name
- Integrated Continuous Glucose Monitoring System, Factory Calibrated
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1355
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 7
- Summaries archived here
- 6 (direct download)
- 510(k) clearances (all years, FDA)
- 18 (all years; only the last 3 years are listed here)
FDA classification definition
An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.
510(k) clearances, last 3 years (7)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K261402 | 2026-06-08 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring System;Dexco… | |
| K253737 | 2026-02-03 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring (CGM) System… | |
| K253710 | 2025-12-17 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring (CGM) System… | |
| K243214 | 2025-04-09 | Dexcom, Inc. | Dexcom G7 15 Day Continuous Glucose Monitoring Syste… | |
| K240902 | 2024-04-23 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring System | |
| K233537 | 2024-04-23 | Abbott Diabetes Care, Inc. | FreeStyle Libre 3 Continuous Glucose Monitoring Syst… | FDA |
| K234133 | 2024-02-26 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring System |
Official FDA classification page: QBJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).